Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
Lorenzen S, Götze TO, Thuss-Patience P, Biebl M, Homann N, Schenk M, Lindig U, Heuer V, Kretzschmar A, Goekkurt E, Haag GM, Riera-Knorrenschild J, Bolling C, Hofheinz RD, Zhan T, Angermeier S, Ettrich TJ, Siebenhuener AR, Elshafei M, Bechstein WO, Gaiser T, Loose M, Sookthai D, Kopp C, Pauligk C, Al-Batran SE; AIO and SAKK Study Working Groups.
J Clin Oncol. 2024 Feb 1;42(4):410-420. doi: 10.1200/JCO.23.00975. Epub 2023 Nov 14.
Peroral Esophageal Myotomy.
Drexel S, Kishawi S, Marks J.
Surg Clin North Am. 2020 Dec;100(6):1183-1192. doi: 10.1016/j.suc.2020.08.004. Epub 2020 Oct 10.
POEM for Achalasia.
Kroch DA, Grimm IS.
Am Surg. 2018 Apr 1;84(4):489-495.
Progress of preoperative and postoperative radiotherapy in gastric cancer.
Zhang N, Fei Q, Gu J, Yin L, He X.
World J Surg Oncol. 2018 Sep 13;16(1):187. doi: 10.1186/s12957-018-1490-7.
Effects of preoperative nutrition on postoperative outcomes in esophageal cancer: a systematic review and meta-analysis.
Cao Y, Han D, Zhou X, Han Y, Zhang Y, Li H.
Dis Esophagus. 2022 Mar 12;35(3):doab028. doi: 10.1093/dote/doab028.
Effects of bariatric surgery on the esophagus.
Savarino E, Marabotto E, Savarino V.
Curr Opin Gastroenterol. 2018 Jul;34(4):243-248. doi: 10.1097/MOG.0000000000000439.
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Wang Y, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E J, Ying X, Yao C, Shen L, Ji J.
Lancet Oncol. 2025 Mar;26(3):312-319. doi: 10.1016/S1470-2045(24)00676-4. Epub 2025 Feb 11.
Comparison of postoperative survival between early-onset and late-onset adenocarcinoma of esophagogastric junction: a population-based study.
Chen L, Jin T, Fang Y, Wu G, Yuan Y.
J Gastroenterol Hepatol. 2024 Jun;39(6):1073-1081. doi: 10.1111/jgh.16514. Epub 2024 Feb 14.
Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.
Chumpitazi BP, Kearns GL, Shulman RJ.
Aliment Pharmacol Ther. 2018 Mar;47(6):738-752. doi: 10.1111/apt.14519. Epub 2018 Jan 26.
[Related factors of postoperative complications of radical resection for adenocarcinoma of esophagogastric junction].
Lei TX, Song W.
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Feb 25;25(2):131-134. doi: 10.3760/cma.j.cn441530-20211115-00461.
